Utilization of extracorporeal membrane oxygenation in congenital hypertrophic cardiomyopathy caused by maternal diabetes.
Extracorporeal membrane oxygenation (ECMO) is an advanced strategy utilized in many neonatal intensive care units for a specific list of indications. This case illustrates a rare but effective use of this therapy for a newborn infant with severe hypertrophic cardiomyopathy induced by maternal diabetes. Such infants who are unresponsive to conventional therapies may benefit from ECMO support, if it is used in conjunction with management strategies that optimize cardiac output.
Section of Neonatology, Department of Pediatrics, Comer Children's Hospital, University of Chicago, Chicago, IL, USA.
B H
BH
Arzuaga
Section of Pediatric Cardiology, Department of Pediatrics, Comer Children's Hospital, University of Chicago, Chicago, IL, USA.
A
A
Groner
D002312:Cardiomyopathy, Hypertrophic / Q000151:congenital / Q000209:etiology / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D015199:Extracorporeal Membrane Oxygenation / Q000379:methods*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal / Q000379:methods*; D011247:Pregnancy; D011248:Pregnancy Complications; D016896:Treatment Outcome
Extracorporeal membrane oxygenation; diabetes mellitus; hypertrophic cardiomyopathy; neonate